Variation in gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma – results of a prospective cohort study
Open Access
- 19 September 2021
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Videosurgery and Other Miniinvasive Techniques
- Vol. 19 (5), 1454-1462
- https://doi.org/10.5114/aoms/142407
Abstract
Introduction: The successful introduction of immune checkpoint blockade approaches to renal-cell carcinoma (RCC) treatment indicates the importance of molecules regulating the T cell response to RCC risk and progression. Material and methods: In this study, we evaluate the association of...This publication has 37 references indexed in Scilit:
- Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung CancerPLOS ONE, 2013
- The Metastasis-Associated Gene MTA3, a Component of the Mi-2/NuRD Transcriptional Repression Complex, Predicts Prognosis of Gastroesophageal Junction AdenocarcinomaPLOS ONE, 2013
- CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancerHuman Immunology, 2011
- Polymorphisms in the cytotoxic T‐lymphocyte antigen 4 gene and cancer riskCancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang ProvinceBreast Cancer Research and Treatment, 2009
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodiesThe Journal of Experimental Medicine, 2009
- CTLA-4 trafficking and surface expressionTrends in Immunology, 2008
- Enhancement of Antitumor Immunity by CTLA-4 BlockadeScience, 1996
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994